tiprankstipranks
Trending News
More News >
Harrow confident in 2025 revenue target $280M, consensus $283.19M
PremiumThe FlyHarrow confident in 2025 revenue target $280M, consensus $283.19M
1M ago
Harrow expands Vevye Access for All program
Premium
The Fly
Harrow expands Vevye Access for All program
2M ago
Harrow price target lowered to $65 from $69 at B. Riley
Premium
The Fly
Harrow price target lowered to $65 from $69 at B. Riley
2M ago
Harrow reports Q4 core EPS 40c, consensus 13c
PremiumThe FlyHarrow reports Q4 core EPS 40c, consensus 13c
2M ago
CMS approves Harrow’s pass-through application for corticosteroid TRIESENCE
Premium
The Fly
CMS approves Harrow’s pass-through application for corticosteroid TRIESENCE
3M ago
Harrow Health: Strong Financial Performance and Strategic Initiatives Drive Buy Rating with 40% Revenue Growth Outlook
Premium
Ratings
Harrow Health: Strong Financial Performance and Strategic Initiatives Drive Buy Rating with 40% Revenue Growth Outlook
3M ago
Harrow sees Q4 revenue $65M-$67M, consensus $58.4M
PremiumThe FlyHarrow sees Q4 revenue $65M-$67M, consensus $58.4M
3M ago
Harrow sees FY24 revenue $198M-$200M, consensus $191.2M
Premium
The Fly
Harrow sees FY24 revenue $198M-$200M, consensus $191.2M
3M ago
Harrow Health options imply 17.9% move in share price post-earnings
Premium
The Fly
Harrow Health options imply 17.9% move in share price post-earnings
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100